Preventive Antiepileptic Therapy in Patients With Tuberous Sclerosis

Григорьева, А. В.; Дорофеева, М. Ю.; Gorchkhanova, Z. K.; Perminov, Vladislav; Belousova, Elena

doi:10.17650/2073-8803-2017-12-2-34-39

Rus. ž. det. nevrol.

2017

DOI: 10.17650/2073-8803-2017-12-2-34-39

|View full text |Cite

Preventive Antiepileptic Therapy in Patients With Tuberous Sclerosis

А. В. Григорьева¹,

М. Ю. Дорофеева²,

Z. K. Gorchkhanova³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk

Zhuravlev¹,

Shnayder

Vaiman³

et al. 2022

jour

View full text Add to dashboard Cite

In connection with the widespread use of anticonvulsants (antiepileptic drugs – AEDs) in psychiatric and neurological practice and the need for their long-term use to treat a wide range of mental disorders and neurological diseases, the question of their safety profile, including the assessment of the risk of developing life-threatening conditions and adverse reactions (ADRs), becomes relevant. In this regard, from the position of personalized medicine, it is critical to develop an interdisciplinary approach with the participation of doctors of various specialties and a new strategy of a personalized approach to predicting AED-induced prolongation of the QT interval as one of the most prognostically unfavorable cardiological ADRs (including sudden death syndrome – SDS). We searched for full-text publications for the period from 2011 to 2021 databases using the following keywords and its combination. We have found and systematized monogenic and multifactorial forms of long QT syndrome (LQTS) and candidate genes that slow down AEDs metabolism in the liver. Identification of risk alleles of single nucleotide variants (SNVs) of the candidate genes predisposing to the development of AED-induced LQTS and SDS will make it possible to adjust the choice and dosage of these drugs and prevent the development of ADRs, which will improve the quality of life of patients and prevent SDS in the patients with psychiatric and neurological disorders.

show abstract

Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk

Zhuravlev¹,

Shnayder

Vaiman³

et al. 2022

jour

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Preventive Antiepileptic Therapy in Patients With Tuberous Sclerosis

Cited by 1 publication

References 11 publications

Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk

Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk

Contact Info

Product

Resources

About